The American Journal of Managed Care1d
FDA Approves Ranibizumab Implant in Treatment of DME
The ranibizumab injection could be administered in a convenient schedule twice per year for the treatment of diabetic macular ...
Pharm Exec1d
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...
Business Wire1d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
WebMD2y
Understanding Insulin Injections
When it comes to type 2 diabetes, using injectables can be the most effective way to balance blood sugar levels. Understanding both the benefits and the side effects of injectables will promote a ...
Medscape25d
The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy
Diabetes. 2005;54(7):2188-2197.
WebMD1y
Why Prescribe an Injectable?
Patients with type 2 diabetes have a component of insulin resistance ... Understandably, no one likes the idea of taking an injection. However, newer forms of syringes and pens have made ...
Hosted on MSN1mon
Hong Kong could be first to get Swiss start-up’s drug for diabetic eye disease
Oculis' OCS-01 eye drops, currently in phase 3 trials for diabetic ... adhere to the injection-treatment regime and respond well, they can only regain half their lost visual acuity.